CLINICAL_TRIALS
research
· 2015-09-25
Clinical Trial Update: Botulinum Toxin Injection to Prevent Ventricular Arrhythmias [Phase 1]
Summary
Phase 1 study evaluating botulinum toxin injections to prevent ventricular arrhythmias in patients with symptomatic ventricular asystole or ventricular tachycar…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Symptomatic Ventricular Asystolia, Ventricular Tachycardia | Phase 1 | Status: UNKNOWN